Abstract
A previous study has shown that lipophilic prodrugs can be delivered efficiently to normal lung endothelium by incorporation into liposomes covalently conjugated to monoclonal antibody (mAb) 34A against the lung endothelial anticoagulant protein thrombomodulin. In the present study, the potential use of these lung-targeted immunoliposomes (34A-liposomes) for delivery of a lipophilic prodrug, 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine (dpFUdR), to the tumor-bearing lung was examined using BALB/c mice bearing experimental lung metastasis induced by i.v. injection of EMT-6 mouse mammary tumor cells. Immunohistochemical examination of the tumor-bearing lung showed specificity of mAb 34A to lung endothelium. Tumor cells appeared to localize just outside of the normal blood vessels and were within a small diffusion distance from the mAb 34A-binding sites.111In-labeled 34A-liposomes containing monosialoganglioside (GM1) were prepared that included [3H]-dpFUdR at 3.0 mol% in the lipid mixture. In vitro cell binding studies further demonstrated that 34A-liposomes bound specifically to normal mouse lung cells that expressed thrombomodulin but not to EMT-6 cells. Biodistribution study showed efficient and immunospecific accumulation of [3H]-dpFUdR incorporated into 34A-liposomes in the lung at a level parallel with that of111In-labeled 34A-liposomes, indicating that the drug is delivered to the target organ in intact liposomes. Liposomal dpFUdR appeared to be metabolized in the lung to the parent drug FUdR at a rate slower than in the liver and spleen. Furthermore, treatment of lung-metastasis-bearing mice with dpFUdR incorporated into 34A-liposomes on days 1 and 3 after tumor cell injection resulted in a significant increase in the median survival time of treated mice as compared with control mice (%T/C value, 165%). dpFUdR either dispersed in emulsion or incorporated into antibody-free liposomes was ineffective in prolonging the survival of mice. These results indicate the potential effectiveness of organ-specific immunoliposomes containing a lipophilic prodrug for the targeted therapy of metastatic tumors.
Similar content being viewed by others
Abbreviations
- Chol :
-
Cholesterol
- dpFUdR :
-
3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine
- DTPA-SA :
-
diethylenetriamine pentaacetic acid distearylamide complex
- G M 1 :
-
monosialoganglioside
- IC 50 :
-
50% inhibitory concentration
- mAb :
-
monoclonal antibody
- MST :
-
mean survival time
- NGPE :
-
N-glutaryl phosphatidylethanolamine
- NMLC :
-
normal mouse lung cells
- OG :
-
octyl-β-d-glucopyranoside
- PBS :
-
phosphate-buffered saline
- PC :
-
egg phosphatidylcholine
- %T/C :
-
(median survival time of treated mice divided by the median survival time of control mice) x100
- RES :
-
reticuloendothelial system
References
Brodsky FM (1988) Monoclonal antibodies as magic bullets. Pharm Res 5: 1
Rowlinson-Busza G, Epenetos AA (1992) Targeted delivery of biologic and other antineoplastic agents. Curr Opin Oncol 4: 1142
Kosmas C, Linardou H, Epenetos AA (1993) Review: advances in monoclonal antibody tumour targeting. J Drug Targeting 1: 81
Jain RK (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 9: 253
Rorvik MC, Allison DP, Hotchkiss JA, Witschi HP, Kennel SJ (1988) Antibodies to mouse lung capillary endothelium. J Histochem Cytochem 36: 741
Ford VA, Stringer C, Kennel SJ (1992) Thrombomodulin is preferentially expressed in BALB/c lung microvessels. J Biol Chem 267: 5446
Kennel SJ, Lankford T, Hughes B, Hotchkiss JA (1988) Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay. Lab Invest 59: 692
Kennel SJ, Lee R, Bultman S, Kabalka G (1990) Rat monoclonal antibody distribution in mice: an epitope inside the lung vascular space mediated very efficient localization. Nucl Med Biol 17: 193
Wright S, Huang L (1989) Antibody-directed liposomes as drug-delivery vehicles. Adv Drug Deliv Rev 3: 343
Ostro MJ (ed) (1987) Liposomes: from biophysics to therapeutics. Marcel Dekker, New York
Hughes BJ, Kennel S, Lee R, Huang L (1989) Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res 49: 6214
Holmberg E, Maruyama K, Litzinger DC, Wright S, Davis M, Kabalka GW, Kennel SJ, Huang L (1989) Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions. Biochem Biophys Res Commun 165: 1272
Maruyama K, Holmberg E, Kennel SJ, Klibanov A, Torchilin VP, Huang L (1990) Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J Pharm Sci 79: 978
Holmberg E, Maruyama K, Kennel S, Klibanov A, Torchilin V, Ryan U, Huang L (1990) Target-specific binding of immunoliposomes in vivo. J Liposome Res 1: 393
Mori A, Liu D, Huang L (1992) Novel immunoliposome targeting system avoiding reticuloendothelial cell. In: Junginger HE (ed) Drug targeting and delivery: concepts in dosage form design. Ellis Horwood, New York, p 26
Maruyama K, Kennel SJ, Huang L (1990) Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc Natl Acad Sci USA 87: 5744
Mori A, Klibanov AL, Torchilin VP, Huang L (1991) Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett 284: 263
Litzinger DC, Huang L (1992) Biodistribution and immunotarget-ability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes. Biochim Biophys Acta 1104: 179
Mori A, Kennel SJ, Huang L (1993) Immunotargeting of liposomes containing lipophilic antitumor prodrugs. Pharm Res 10: 507
Kabalka G, Buonocore E, Hubner K, Moss T, Norley N, Huang L (1987) Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. Radiology 163: 255
Schwendener RA, Supersaxo A, Rubas W, Weder HG, Hartmann HR, Schott H, Ziegler A, Hengartner H (1985) 5′-O-Palmitoyl- and 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine-novel lipophilic anlogues of 5-fluoro-2′-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological results. Biochem Biophys Res Commun 126: 660
Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268: 235
Borssum Waalkes M van, Galen M van, Morselt H, Sternberg B, Scherphof GL (1993) In vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2′-deoxyuridine and its diacylated derivatives. Biochim Biophys Acta 1148: 161
Kennel SJ, Foote LJ, Lankford PK (1981) Analysis of surface proteins of mouse lung carcinomas using monoclonal antibodies. Cancer Res 41: 3465
Kennel SJ, Foote LJ, Flynn KM (1986) Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay. Cancer Res 46: 707
Rockwell SC, Kallman RF, Fajardo LF (1972) Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl Cancer Inst 49: 735
Rockwell S (1977) In vivo-in vitro tumor systems: new models for studying the response of tumor to therapy. Lab Animal Sci 27: 831
Mori A, Huang L (1992) Immunoliposome targeting in a mouse model: optimization and therapeutic application. In: Gregoriadis G (ed) Liposome technology, 2nd edn, vol. III. CRC Press, Boca Raton, p 153
Osterman LA (ed) (1984) The use of radioisotopes. In: Methods of protein and nucleic acid research. Springer, New York Berlin Heidelberg, p 67
Wu MS, Robbins JC, Bugianesi RL, Ponpipom MM, Shen TY (1981) Modified in vivo behavior of liposomes containing synthetic glycolipids. Biochim Biophys Acta 674: 19
Derksen JTP, Morselt HWM, Kalicharan D, Hulstaert CE, Scherphof GL (1987) Interaction of immunoglobulin-coated liposomes with rat liver macrophages in vitro. Exp Cell Res 168: 105
Aragnol D, Leserman L (1986) Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc Natl Acad Sci USA 83: 2699
Borssum Waalkes M van (1992) Lipophilic derivatives of 5-fluoro-2′-deoxyuridine as liposomal anticancer agents. Thesis, Groningen University, Groningen, The Netherlands
Schwendener RA (1986) The preparation of large volumes of homogeneous, sterile liposomes containing various lipophilic cytotoxic drugs by the use of a capillary dialyzer. Cancer Drug Deliv 3: 123
Nishizawa Y, Casida JE, Anderson SW, Heidelberger C (1965) 3′,5′-Diesters of 5-fluoro-2′-deoxyuridine: synthesis and biological activity. Biochem Pharmacol 14: 1605
Supersaxo A, Rubas W, Hartmann H, Schott H, Hengartner H, Schwendener RA (1988) The antitumor effect of lipophilic derivatives of 5-fluoro-2′-deoxyuridine incorporated into liposomes. J Microencapsulation 5: 1
Borssum Waalkes M van, Scherphof GL (1990) Liposome-incorporated 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine as a slow-release anti-tumor drug depot in rat liver macrophages. Select Cancer Ther 6: 15
Borssum Waalkes M van, Fichtner I, Dontje BHJ, Lemm M, Becker M, Arndt D, Scherphof GL (1992) In vivo distribution and antitumor activity of liposomal 3′, 5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine. J Microencapsulation 9: 335
Blumenthal RD, Sharkey RM, Haywood L, Natale AM, Wong GY, Siegel JA, Kennel SJ, Goldenberg DM (1992) Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with131I-labeled monoclonal antibody. Cancer Res 52: 6036
Ahmad I, Allen TM (1992) Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Cancer Res 52: 4817
Ahmad I, Longenecker M, Samuel J, Allen TM (1993) Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 53: 1484
Author information
Authors and Affiliations
Additional information
This manuscript was authored by a contractor of the United States Government under contract DE-AC05-84OR21400. Accordingly, the United States Government retains a nonexclusive, royalty-free licence to publish or reproduce the published form of this contribution, or to allow others to do so, for United States Government purposes.
Rights and permissions
About this article
Cite this article
Mori, A., Kennel, S.J., van Borssum Waalkes, M. et al. Characterization of organ-specific immunoliposomes for delivery of 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine in a mouse lung-metastasis model. Cancer Chemother. Pharmacol. 35, 447–456 (1995). https://doi.org/10.1007/BF00686828
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686828